Lucid Diagnostics: Strong Demand and Strategic Advancements Drive ‘Buy’ Rating
In a report released yesterday, Anthony Vendetti from Maxim Group reiterated a Buy rating on Lucid Diagnostics (LUCD – Research Report), ...